During COVID-19, Medicare expanded telehealth access by waiving geographic restrictions, broadening provider eligibility, and covering more services. These temporary flexibilities are set to expire at the end of 2024, requiring providers to adjust to stricter pre-pandemic rules unless Congress intervenes.
View Article >>Actionable steps to properly establish, document, and maintain these relationships, minimizing risks and enhancing compliance.
View Article >>Top 10 list of common telehealth compliance mistakes, with practical advice on how to identify and correct each issue.
View Article >>Discuss the DEA/HHS joint rule extending the prescribing flexibilities for controlled substances. Include: 1) an overview of the prescribing flexibilities that emerged during the COVID pandemic re: controlled substances; 2) the details of the proposed rule, and 3) what the rule means for providers.
View Article >>Offer telehealth providers a practical guide to navigating billing and reimbursement challenges specific to virtual care. This article will delve into coding practices, reimbursement parity, and strategies to optimize revenue by understanding insurer requirements for telehealth.
View Article >>We examine the complex requirements and risks associated with informed consent for telehealth providers. The article provides actionable advice on navigating the regulatory landscape and practical steps to ensure legal compliance and patient safety.
View Article >>